Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chemotherapy and Imatinib in Ph+ ALL Young Adults
NCT01491763Phase 4Unknown
- Sponsor
- Fundación PETHEMA
- Start
- Jan 2008
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of imatinib in acute lymphoblastic leukemia (ALL), sponsored by Fundación PETHEMA. Status: unknown.
02
Drugs
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT01491763.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01491763.